NK01-63 (Coronastat) is a potent inhibitor of the SARS-CoV-2 3CL protease, which is a critical drug target for small molecule COVID-19, given its likely druggability and essentiality in the viral maturation and replication cycle.
[1] Liu H, et al. Nat Commun. 2022 Apr 7;13(1):1891.
















